GlassScriptPhysician profile
Roxane Handal-Orefice
NPI 1124461066
$1,229.37
in general payments reported to CMS, 2019-2025
21 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $69.47 · 2022: $202 · 2023: $294 · 2024: $371 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $170.65 | 2024-2025 | Veozah |
| Abbvie INC. | $164.50 | 2023-2024 | |
| Pfizer INC. | $146.76 | 2023-2025 | |
| Daiichi Sankyo INC. | $132.00 | 2022-2024 | Injectafer |
| Biogen, INC. | $108.32 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $65.06 | 2021-2022 | |
| Agile Therapeutics, INC. | $56.41 | 2022-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $47.48 | 2023-2025 | |
| Hologic Sales and Service, LLC | $38.45 | 2022-2024 | Novasure, Omni Hysteroscope |
| Shield Therapeutics INC | $36.29 | 2023-2024 | Accrufer |
| Axonics, INC. | $35.97 | 2024 | Bulkamid, Axonics |
| Novo Nordisk INC | $32.81 | 2023-2024 | Wegovy |
| Mayne Pharma Commercial LLC | $32.26 | 2022 | |
| Convatec INC. | $25.55 | 2023 | |
| Sage Therapeutics, LLC | $24.85 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $22.24 | 2021 | |
| Organon LLC | $21.32 | 2021 | |
| Medtronic, INC. | $20.85 | 2025 | Truclear |
| Sumitomo Pharma America, INC. | $18.20 | 2024 | Myfembree |
| Olympus America INC. | $17.31 | 2023 | Olympus |
| Coopersurgical, INC. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roxane Handal-Orefice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.